Astellas Pharma | 4503 - Interest Expense On Debt


Astellas Pharma reported JPY3.91B in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Astellas Pharma JPY 3.91B 320M Mar/2025
Chugai Pharma JPY 95M 260M Dec/2025
Daiichi Sankyo JPY 3.57B 1.4B Mar/2026
Eisai JPY 1.96B 409M Jun/2026
Kyowa Hakko Kirin JPY 2.27B 1.84B Mar/2026
M3 JPY 259M 31M Mar/2026
Otsuka Holdings JPY 2.21B 866M Dec/2025
Shionogi JPY 5.32B 2.48B Jun/2026
Sumitomo Dainippon JPY 460M 15.14B Mar/2026
Takeda JPY 63.85B 20.2B Jun/2026
Terumo JPY 1.53B 1.06B Mar/2026